Melanie J. Herman
2015
In 2015, Melanie J. Herman earned a total compensation of $632.6K as Chief Accounting Officer and former Interim Chief Financial Officer at Ligand Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $38,207 |
|---|---|
| Option Awards | $290,004 |
| Salary | $191,035 |
| Stock Awards | $67,512 |
| Other | $45,857 |
| Total | $632,615 |
Herman received $290K in option awards, accounting for 46% of the total pay in 2015.
Herman also received $38.2K in non-equity incentive plan, $191K in salary, $67.5K in stock awards and $45.9K in other compensation.
Rankings
In 2015, Melanie J. Herman's compensation ranked 9,918th out of 13,638 executives tracked by ExecPay. In other words, Herman earned more than 27.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,918 out of 13,638 | 27th |
Division Manufacturing | 3,789 out of 5,187 | 27th |
Major group Chemicals And Allied Products | 1,388 out of 1,857 | 25th |
Industry group Drugs | 1,139 out of 1,531 | 26th |
Industry Pharmaceutical Preparations | 890 out of 1,179 | 25th |
Source: SEC filing on April 12, 2016.
Herman's colleagues
We found five more compensation records of executives who worked with Melanie J. Herman at Ligand Pharmaceuticals in 2015.
2015
John Higgins
Ligand Pharmaceuticals
Chief Executive Officer
2015
Matthew Foehr
Ligand Pharmaceuticals
Chief Operating Officer
2015
Matthew Korenberg
Ligand Pharmaceuticals
Chief Financial Officer
2015
Nishan de Silva
Ligand Pharmaceuticals
Chief Financial Officer
2015
Charles Berkman
Ligand Pharmaceuticals